Kate Rausch

Kate Rausch is an experienced executive in investor relations and corporate affairs, currently serving as Vice President at Wave Life Sciences since April 2019. Prior to this role, Kate held the position of Director of Investor Relations at TESARO, Inc. from March 2016 until its acquisition by GSK in January 2019. Kate's career also includes roles as a Senior Equity Research Associate at Jefferies & Company and an Equity Research Associate at CLSA and Gleacher & Company. Educational credentials include a Master of Science in Biomedical Engineering from Tufts University, participation in the Business Bridge Program at The Tuck School of Business at Dartmouth, and a Bachelor of Science in Engineering with a concentration in Biomedical Engineering from Trinity College-Hartford. The academic journey began at Middlesex School, culminating in a high school diploma.